<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Revisiting Rheumatic Fever and RHD</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="cardiology-preventive-cardiology.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 90.4%;"></div> <!-- Set percentage dynamically with static value for this chunk -->
                        </div>
                       <span class="progress-text">Lecture 47 of 52</span> <!-- Update text with static value for this chunk -->
                    </div>
                    <a href="cardiology-congenital-heart-disease-A.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">ACUTE RHEUMATIC FEVER</h1>
                <p>CARDIOLOGY LECTURES 3RD YEAR - FEBRUARY 2009</p>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: introduction -->
                <section id="introduction" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">INTRODUCTION</span>
                    </h2>
                    <div class="content-card">
                        <p>Acute rheumatic fever (ARF) is a delayed, nonsuppurative sequela of a pharyngeal infection with the group A streptococcus (GAS). Following the initial pharyngitis, a latent period of two to three weeks occurs before the first signs or symptoms of ARF appear [1].</p>
                    </div>
                </section>
                <!-- END: introduction -->

                <!-- START: definitions -->
                <section id="definitions" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">DEFINITIONS</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Delayed nonsuppurative sequelae of upper respiratory tract infection with group A beta hemolytic streptococcus.</li>
                            <li>Post infectious or connective tissue disease.</li>
                            <li>A diffuse inflammatory disease of the connective tissue involving chiefly the heart, joints, blood vessels, and subcutaneous tissues.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: definitions -->

                <!-- START: importance -->
                <section id="importance" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">IS IT STILL IMPORTANT?</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Its incidence/prevalence- WHO 12 million people suffered RF&RHD worldwide</li>
                            <li>3 million had CCF requiring repeated hospitalizations</li>
                            <li>1 million requiring surgery annually</li>
                            <li>Mortality- 500,000 dead by one year</li>
                            <li>Disability adjusted life year lost to RHD worldwide 173.4 per 100,000 population</li>
                        </ul>
                    </div>
                </section>
                <!-- END: importance -->

                <!-- START: problem -->
                <section id="problem" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">WHY IS THERE STILL A PROBLEM?</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>The same old problem</li>
                            <li>The devastating new ones</li>
                            <li>Chronic lack of resources</li>
                            <li>Morbidity and Mortality in Paediatric population still high</li>
                            <li>It is a preventable disease.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: problem -->

                <!-- START: etiology-epidemiology -->
                <section id="etiology-epidemiology" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">AETIOLOGY & EPIDEMIOLOGY</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Group A streptococcus the aetiologic precursor</li>
                            <li>Role of constitutional and environmental factors unknown</li>
                            <li>Familial susceptibility is significant</li>
                            <li>Malnutrition, overcrowding and lower socioeconomic status seem to predispose to streptococcal infections and subsequent rheumatic attacks</li>
                            <li>Risk factors for rheumatic fever and rheumatic heart disease</li>
                            <li>Poverty and overcrowding, poor sanitary conditions, lack of education and limited access to medical care for adequate diagnosis and treatment are recognised as contributing factors to rheumatic fever.</li>
                        </ul>
                        <h3 class="subsection-heading">EPIDEMIOLOGY Cont</h3>
                        <ul>
                            <li>In developed countries, control of RF followed by apparent resurges- a warning to the ever existing potential to the presence of disease</li>
                            <li>Rates of decline related to
                                <ul>
                                    <li>use of antibiotics for the treatment of streptococcal pharyngitis,</li>
                                    <li>Improved economic standards</li>
                                    <li>Decreased crowding in schools and homes</li>
                                    <li>Increased availability of Health care</li>
                                    <li>Change in the virulence of the organism</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: etiology-epidemiology -->

                <!-- START: pathogenesis -->
                <section id="pathogenesis" class="content-section" aria-labelledby="section-heading-6">
                    <h2 id="section-heading-6" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Pathogenesis</span>
                    </h2>
                    <div class="content-card">
                        <figure>
                            <figcaption>The streptococcus</figcaption>
                            <img src="../assets/images/2025_06_29_003bffb31f3a2a368f32g-09-1.jpg" alt="Schematic diagram showing the structure of the streptococcal cell wall and its cross-reactivity with mammalian heart structures." class="content-image">
                            <figcaption>Fig. 86-1. Schematic diagram showing the structure of the streptococcal cell wall. The fimbriae covered with lipoteichoic acid help the organism adhere to the throat epithelium (adherence factor). These fimbriae, being projections from the protein layer of the cell wall, contain M-protein, a virulence factor. Each of the different layers of the cell wall and the cytoplasmic membrane have been shown to cross-react with different antigens and different structures of the mammalian heart, including the human heart.</figcaption>
                        </figure>
                        <h3 class="subsection-heading">Immune Response Pathogenesis</h3>
                        <ol>
                            <li>B lymphocytes produce antibodies.</li>
                            <li>M protein peptides combined with HLA class II molecules are presented to the CD4+ T lymphocytes.</li>
                            <li>CD4+ T lymphocytes become memory cells.</li>
                            <li>In the periphery, a humoral and cellular response against M protein peptides and heart tissue proteins occurs.</li>
                            <li>M peptides / myocardium and valvular proteins lead to cross-reactive CD4+ infiltrating T cell clones.</li>
                            <li>Mononuclear cells produce TNF-α and IFN-γ.</li>
                            <li>This leads to Tissue Damage.</li>
                        </ol>
                    </div>
                </section>
                <!-- END: pathogenesis -->

                <!-- START: diagnostic-difficulty -->
                <section id="diagnostic-difficulty" class="content-section" aria-labelledby="section-heading-7">
                    <h2 id="section-heading-7" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Difficulty relating to nature of the disease</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Varied clinical profile</li>
                            <li>Sub-clinical course</li>
                            <li>Lack of specific diagnostic test</li>
                            <li>Accuracy of reporting cases of RF & RHD</li>
                        </ul>
                        <h3 class="subsection-heading">Major criteria</h3>
                        <ul>
                            <li><strong>Carditis:</strong> This occurs in as many as 40% of patients and may include cardiomegaly, new murmur, congestive heart failure, and pericarditis, with or without a rub and valvular disease.</li>
                            <li><strong>Migratory polyarthritis:</strong> This condition occurs in 75% of cases and is polyarticular, fleeting, and involves the large joints.</li>
                            <li><strong>Subcutaneous nodules (ie, Aschoff bodies):</strong> These nodules occur in 10% of patients and are edematous, fragmented collagen fibers. They are firm, painless nodules on the extensor surfaces of the wrists, elbows, and knees.</li>
                            <li><strong>Erythema marginatum:</strong> This condition occurs in about 5% of cases. The rash is serpiginous and long lasting.</li>
                            <li><strong>Chorea (also known as Sydenham chorea and "St Vitus dance"):</strong> This characteristic movement disorder occurs in 5-10% of cases. Sydenham chorea consists of rapid, purposeless movements of the face and upper extremities. Onset may be delayed for several months and may cease when the patient is asleep.</li>
                        </ul>
                        <h3 class="subsection-heading">Minor criteria</h3>
                        <ul>
                            <li>Clinical findings include arthralgia, fever and previous history of ARF</li>
                            <li>Laboratory findings include elevated acute phase reactants (eg, erythrocyte sedimentation rate, C reactive protein), a prolonged PR interval, and supporting evidence of antecedent group A streptococcal infections (ie, positive throat culture or rapid streptococcal screen and an elevated or rising streptococcal antibody titer).</li>
                        </ul>
                    </div>
                </section>
                <!-- END: diagnostic-difficulty -->

                <!-- START: jones-criteria -->
                <section id="jones-criteria" class="content-section" aria-labelledby="section-heading-8">
                    <h2 id="section-heading-8" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">JONES CRITERIA</span>
                    </h2>
                    <div class="content-card">
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 4.1 2002-2003 WHO criteria for the diagnosis of rheumatic fever and rheumatic heart disease (based on the revised Jones criteria)</caption>
                                <thead>
                                    <tr>
                                        <th>Diagnostic categories</th>
                                        <th>Criteria</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Primary episode of RF</td>
                                        <td>Two major* or one major and two minor** manifestations plus evidence of a preceding group A streptococcal infection***.</td>
                                    </tr>
                                    <tr>
                                        <td>Recurrent attack of RF in a patient without established rheumatic heart disease.</td>
                                        <td>Two major or one major and two minor manifestations plus evidence of a preceding group A streptococcal infection.</td>
                                    </tr>
                                    <tr>
                                        <td>Recurrent attack of RF in a patient with established rheumatic heart disease.</td>
                                        <td>Two minor manifestations plus evidence of a preceding group A streptococcal infection.</td>
                                    </tr>
                                    <tr>
                                        <td>Rheumatic chorea.<br>Insidious onset rheumatic carditis.</td>
                                        <td>Other major manifestations or evidence of group A streptococcal infection not required.</td>
                                    </tr>
                                    <tr>
                                        <td>Chronic valve lesions of RHD (patients presenting for the first time with pure mitral stenosis or mixed mitral valve disease and/or aortic valve disease).</td>
                                        <td>Do not require any other criteria to be diagnosed as having rheumatic heart disease.</td>
                                    </tr>
                                    <tr>
                                        <td>* Major manifestations</td>
                                        <td>
                                            <ul>
                                                <li>carditis</li>
                                                <li>polyarthritis</li>
                                                <li>chorea</li>
                                                <li>erythema marginatum</li>
                                                <li>subcutaneous nodules</li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>** Minor manifestations</td>
                                        <td>
                                            <ul>
                                                <li>clinical: fever, polyarthralgia</li>
                                                <li>laboratory: elevated acute phase reactants (erythrocyte sedimentation rate or leukocyte count)</li>
                                                <li>electrocardiogram: prolonged P-R interval</li>
                                            </ul>
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>*** Supporting evidence of a preceding streptococcal infection within the last 45 days</td>
                                        <td>
                                            <ul>
                                                <li>elevated or rising antistreptolysin-O or other streptococcal antibody, or</li>
                                                <li>a positive throat culture, or</li>
                                                <li>rapid antigen test for group A streptococci, or</li>
                                                <li>recent scarlet fever.</li>
                                            </ul>
                                        </td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <div class="table-container">
                             <table class="content-table">
                                 <caption>Table 4.4: Differential Diagnosis Based on Symptoms/Signs</caption>
                                <thead>
                                    <tr>
                                        <th>Symptom or sign</th>
                                        <th>Possible diagnosis</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Temperature of 40°C</td>
                                        <td>Still's disease<br>Bacterial arthritis<br>Systemic lupus erythematosus</td>
                                    </tr>
                                    <tr>
                                        <td>Fever preceding arthritis</td>
                                        <td>Viral arthritis<br>Lyme disease<br>Reactive arthritis<br>Stills disease<br>Bacterial endocarditis</td>
                                    </tr>
                                    <tr>
                                        <td>Migratory arthritis</td>
                                        <td>RF<br>Gonococcemia<br>Meningococcemia<br>Viral arthritis<br>Systemic lupus erythematosus<br>Acute leukemia<br>Whipple's disease</td>
                                    </tr>
                                    <tr>
                                        <td>Effusion disproportionately greater than pain</td>
                                        <td>Tuberculosis arthritis<br>Bacterial endocarditis<br>Inflammatory bowel disease<br>Giant cell arthritis<br>Lyme disease</td>
                                    </tr>
                                    <tr>
                                        <td>Pain disproportionately greater than effusion</td>
                                        <td>RF<br>Familial Mediterranean fever<br>Acute leukemia<br>AIDS</td>
                                    </tr>
                                    <tr>
                                        <td>Positive test for rheumatoid factor</td>
                                        <td>Rheumatoid arthritis<br>Viral arthritis<br>Tuberculous arthritis<br>Bacterial endocarditis<br>Systemic lupus erythematosus<br>Sarcoidosis<br>Systemic vasculitis</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>
                <!-- END: jones-criteria -->

                <!-- START: clinical-manifestations -->
                <section id="clinical-manifestations" class="content-section" aria-labelledby="section-heading-9">
                    <h2 id="section-heading-9" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Clinical Manifestations</span>
                    </h2>
                    <div class="content-card">
                        <figure>
                            <figcaption><strong>ERYTHEMA MARGINATUM</strong><br>A close view of erythema marginatum.</figcaption>
                            <img src="../assets/images/2025_06_29_003bffb31f3a2a368f32g-17-1.jpg" alt="A close-up photograph of skin showing the characteristic serpiginous, red-bordered rash of erythema marginatum." class="content-image">
                        </figure>
                        <figure>
                            <img src="../assets/images/2025_06_29_003bffb31f3a2a368f32g-18-1.jpg" alt="Image of a patient with erythema marginatum on the trunk." class="content-image">
                        </figure>
                        <h3 class="subsection-heading">Cardiac manifestations</h3>
                        <figure>
                            <img src="../assets/images/2025_06_29_003bffb31f3a2a368f32g-19-1.jpg" alt="Chest X-ray showing cardiomegaly, a common cardiac manifestation of rheumatic fever." class="content-image">
                        </figure>
                        <figure>
                            <img src="../assets/images/2025_06_29_003bffb31f3a2a368f32g-20-1.jpg" alt="Gross pathology image of a heart showing valvular damage from rheumatic heart disease." class="content-image">
                        </figure>
                        <figure>
                            <img src="../assets/images/2025_06_29_003bffb31f3a2a368f32g-21-1.jpg" alt="Gross pathology image showing thickened and fused mitral valve leaflets, characteristic of chronic rheumatic heart disease." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: clinical-manifestations -->

                <!-- START: treatment-goals -->
                <section id="treatment-goals" class="content-section" aria-labelledby="section-heading-10">
                    <h2 id="section-heading-10" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">TREATMENT GOALS</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>All patients with acute rheumatic fever, eradication of the streptococcus an absolute requirement</li>
                            <li>Initiate plans for longterm therapy</li>
                            <li>Need for prophylaxis against bacterial endocarditis</li>
                        </ul>
                        <h3 class="subsection-heading">Component</h3>
                        <ul>
                            <li>Secondary prevention activities aimed at preventing recurrence of RF & Severe RHD</li>
                            <li>Primary prevention activities aimed at preventing the first attack of acute RF</li>
                            <li>Health education facilities</li>
                            <li>Training of Health care providers</li>
                            <li>Epidemiology of surveillance</li>
                            <li>Community involvement</li>
                        </ul>
                    </div>
                </section>
                <!-- END: treatment-goals -->

                <!-- START: prevention-prophylaxis -->
                <section id="prevention-prophylaxis" class="content-section" aria-labelledby="section-heading-11">
                    <h2 id="section-heading-11" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Prevention and Prophylaxis</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">STREPTOCOCCUS ERADICATION</h3>
                        <ul>
                            <li>Streptococcus still universally susceptible to penincillins- I/M Benzathine penicillin 1.2 mega units as a start dose -Or Phenoxybenzathine penicillin (PenV) 250 mg Tid orally for 10days - erythromycin 50 mg/kg/day orally for 10days</li>
                        </ul>
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 3: Primary prevention of rheumatic fever.</caption>
                                <thead>
                                    <tr>
                                        <th>Agent</th>
                                        <th>Therapeutic scheme</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Benzathine penicillin G</td>
                                        <td>600,000 U for patients <27 Kg; 1,200,000 U for patients > 27kg, IM (once) or</td>
                                    </tr>
                                    <tr>
                                        <td>Penicillin V</td>
                                        <td>Children: 250 mg 2-3 times daily, PO (10 d)<br>Adolescents: 500 mg 2-3 times daily, PO (10 d)</td>
                                    </tr>
                                    <tr>
                                        <td colspan="2"><strong>For individuals allergic to penicillin:</strong></td>
                                    </tr>
                                    <tr>
                                        <td>Erythromycin</td>
                                        <td>20-40 mg/kg/day in 2-4 doses PO</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <h3 class="subsection-heading">SECONDARY PREVENTION</h3>
                        <ul>
                            <li>Continuous administration of specific antibiotics to patients with previous attack of RF</li>
                            <li>Mandatory to patients who have had an attack of RF whether or not they have residual rheumatic valvular heart disease</li>
                        </ul>
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Antibiotics used in secondary prophylaxis of RF</caption>
                                <thead>
                                    <tr>
                                        <th>Antibiotic</th>
                                        <th>Mode of adm</th>
                                        <th>Dose</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Benzathine penicillin</td>
                                        <td>single i/m 3-4 wks</td>
                                        <td>1.2 >30kg<br>600 <30kg</td>
                                    </tr>
                                    <tr>
                                        <td>Pen V</td>
                                        <td>Oral</td>
                                        <td>250 mg BD</td>
                                    </tr>
                                    <tr>
                                        <td>Sulfonamide</td>
                                        <td>oral</td>
                                        <td>>30kg 1gm daily<br><30kg 500mg</td>
                                    </tr>
                                    <tr>
                                        <td>Erythromycin</td>
                                        <td>Oral</td>
                                        <td>250 mg twice daily</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <h3 class="subsection-heading">Duration of secondary prophylaxis</h3>
                        <p>Influenced by</p>
                        <ul>
                            <li>Age of patient,</li>
                            <li>Presence of RHD,</li>
                            <li>Time elapsed from the first attack,</li>
                            <li>The number of previous attacks,</li>
                            <li>The degree of crowding in the family,</li>
                            <li>A family history of RHD,</li>
                            <li>Socioeconomic and educational status of the individual,</li>
                            <li>The risk of streptococcal infection in the area</li>
                            <li>Whether the patient is willing to the injections</li>
                            <li>The occupation and place of employment of the patient school teacher, physicians, employees in crowded areas)</li>
                        </ul>
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Suggested duration of Secondary prophylaxis (WHO)</caption>
                                <thead>
                                    <tr>
                                        <th>Category of Patient</th>
                                        <th>Duration of Prophylaxis</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Pt without proven carditis (Or mild or healed carditis)</td>
                                        <td>10 yrs after last attack</td>
                                    </tr>
                                    <tr>
                                        <td>More severe valve disease</td>
                                        <td>Lifelong</td>
                                    </tr>
                                    <tr>
                                        <td>After valve surgery</td>
                                        <td>Life long</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <h3 class="subsection-heading">prevention & control of RF & RHD</h3>
                        <ul>
                            <li><strong>Goals</strong>
                                <ul>
                                    <li>- Reduce morbidity, disability & mortality from RHD</li>
                                </ul>
                            </li>
                            <li>Assessment of prevalence of RF/RHD</li>
                            <li>Implement programmes through ministry of Health and Ministry of Education</li>
                        </ul>
                    </div>
                </section>
                <!-- END: prevention-prophylaxis -->
                
                <!-- START: conclusion -->
                <section id="conclusion" class="content-section" aria-labelledby="section-heading-12">
                    <h2 id="section-heading-12" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Conclusion</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Health Care In Underdeveloped Countries</h3>
                        <ul>
                            <li>Partial coverage of health care</li>
                            <li>Low quality of that care which exists</li>
                            <li>Imperfect conditions for scientific research</li>
                            <li>Deficient registration of the complications occurring in the various subsystem</li>
                            <li>Inaccurate decisions that the disease is disappearing</li>
                        </ul>
                        <h3 class="subsection-heading">Hippocrates</h3>
                        <p>Life is short, the art long, opportunity fleeting, experience treacherous, judgment difficult</p>
                        <h3 class="subsection-heading">FINALLY</h3>
                        <p>OURS IS NOT TO COMPLETE THE TASK YET NEITHER ARE WE FREE TO NEGLECT IT</p>
                    </div>
                </section>
                <!-- END: conclusion -->

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="cardiology-preventive-cardiology.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 90.4%;"></div>
                        </div>
                       <span class="progress-text">Lecture 47 of 52</span>
                    </div>
                    <a href="cardiology-congenital-heart-disease-A.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>